PromarkerD launched in Spain

Proteomics International has officially launched PromarkerD in Spain under a deal with Patia Europe

The PromarkerD test system is the first test globally that is capable of predicting the onset of diabetic kidney disease

The exclusive licence agreement with Patia Europe for Spain is for two years and Proteomics International will receive a royalty on each test sold

The launch coincides with PromarkerD being showcased at the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, 16-20 September 2019

The launch is a pivotal milestone for Proteomics International, providing a platform to broaden awareness of PromarkerD, potentially accelerating the execution of additional licensing transactions

Media Release

  • This field is for validation purposes and should be left unchanged.